MedPath

Enobosarm

Generic Name
Enobosarm
Drug Type
Small Molecule
Chemical Formula
C19H14F3N3O3
CAS Number
841205-47-8
Unique Ingredient Identifier
O3571H3R8N

Overview

Enobosarm has been used in trials studying the treatment of Stress Urinary Incontinence and Triple Negative Breast Cancer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/02/28
Phase 2
Active, not recruiting
2021/10/04
Phase 3
Terminated
2021/05/03
Phase 3
Terminated
2018/06/25
Phase 2
Withdrawn
2018/04/26
Phase 2
Withdrawn
2017/08/29
Phase 1
Completed
2017/08/07
Phase 2
Completed
2016/11/23
Phase 2
Completed
City of Hope Medical Center
2016/01/18
Phase 2
Completed
2015/06/04
Phase 2
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath